BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 34620236)

  • 1. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
    Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
    J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation syndrome associated with systemic lupus erythematosus treated successfully with the combination of steroid pulse, immunoglobulin and tacrolimus.
    Aoyama-Maeda N; Horino T; Ichii O; Terada Y
    Rom J Intern Med; 2018 Jun; 56(2):117-121. PubMed ID: 29099692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ; Wu JJ; Song Y; Mei CL; DU R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1111-1117. PubMed ID: 38101797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-α induced systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report and literature review.
    Zeng Z; Tu W; Ji B; Liu J; Huang K; Nie D; Yang L
    Front Immunol; 2023; 14():1223062. PubMed ID: 37600795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe and life-threatening onset of systemic lupus erythematosus.
    Martins A; Pimenta S; Oliveira D; Martins F; Samões B; Costa L
    Reumatol Clin (Engl Ed); 2023; 19(7):402-403. PubMed ID: 37661117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute respiratory distress syndrome associated with macrophage activation syndrome in systemic lupus erythematosus: A case report and literature review.
    Chang ES; Yu HH; Wu CE; Chan TM
    Medicine (Baltimore); 2022 Feb; 101(5):e28612. PubMed ID: 35119005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unmasking of systemic lupus erythematosus in a patient with hemophagocytic lymphohistiocytosis- macrophage activation syndrome (HLA-MAS) and diffuse alveolar hemorrhage.
    Sukhadiya P; Kumar P; Meena DS; Kumar P H A; Vijayan N; Garg P; Garg MK
    Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
    Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful therapy of macrophage activation syndrome with dexamethasone palmitate.
    Nakagishi Y; Shimizu M; Kasai K; Miyoshi M; Yachie A
    Mod Rheumatol; 2016 Jul; 26(4):617-20. PubMed ID: 24754272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
    Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
    Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Activation Syndrome as Onset of Systemic Lupus Erythematosus: A Case Report and a Review of the Literature.
    Granata G; Didona D; Stifano G; Feola A; Granata M
    Case Rep Med; 2015; 2015():294041. PubMed ID: 26064125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
    Torres Jiménez A; Solís Vallejo E; Zeferino Cruz M; Céspedes Cruz A; Sánchez Jara B
    Reumatol Clin; 2014; 10(5):331-5. PubMed ID: 24035795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
    Shah K; Porter A; Takhar G; Reddy V
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
    Takizawa Y; Maruyama J; Setoguchi K
    Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
    Jiang N; Li MT; Wu D; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
    [No Abstract]   [Full Text] [Related]  

  • 19. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.